Iovance Biotherapeutics, Inc. <IOVA.O>: Barclays Raises Target Price to $15 From $13
IOVA•Related News
Centrus signs multi-year HALEU supply contract with Antares Nuclear
LEU•
Huntington Bancshares Inc. <HBAN.O>: Wells Fargo cuts target price to $21 from $23
HBAN•
iBio Inc <IBIO.O>: H.C. Wainwright initiates coverage with buy rating; target price $7
IBIO•
ON Semiconductor Corporation <ON.O>: Wells Fargo cuts target price to $85 from $95
ON•
Salesforce, Inc. <CRM.N>: Citigroup raises target price to $263 from $233
CRM•